The latest quarterly R&D expense is $600.35 Thousand with a QoQ Growth of +46.05%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $600353.00.
$600.35K
$600.35 Thousand
Q2 FY2026 · 2026-06-30
+46.05%
vs. $411.05K prior quarter
22
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $600.35K | +46.05% | -20.95% |
| Q1 FY2026Period end 2026-03-31 | $411.05K | N/A | -11.93% |
| Q4 FY2025Period end 2025-12-31 | −$2.04M | N/A | N/A |
| Q3 FY2025Period end 2025-09-30 | $816.70K | +7.54% | +788.57% |
| Q2 FY2025Period end 2025-06-30 | $759.45K | +62.71% | +651.36% |
| Q1 FY2025Period end 2025-03-31 | $466.75K | +132.21% | +373.05% |
| Q4 FY2024Period end 2024-12-31 | $201.00K | +118.70% | -17.87% |
| Q3 FY2024Period end 2024-09-30 | $91.91K | -9.07% | -61.62% |
| Q2 FY2024Period end 2024-06-30 | $101.08K | +2.44% | -50.26% |
| Q1 FY2024Period end 2024-03-31 | $98.67K | -59.68% | -63.10% |
| Q4 FY2023Period end 2023-12-31 | $244.73K | +2.20% | N/A |
| Q3 FY2023Period end 2023-09-30 | $239.46K | +17.85% | N/A |
| Q2 FY2023Period end 2023-06-30 | $203.20K | -24.01% | N/A |
| Q1 FY2023Period end 2023-03-31 | $267.41K | N/A | N/A |
| Q2 FY2022Period end 2022-06-30 | $252.15K | +38.03% | -49.01% |
| Q1 FY2022Period end 2022-03-31 | $182.68K | -50.92% | -35.44% |
| Q4 FY2021Period end 2021-12-31 | $372.19K | +24.89% | -57.70% |
| Q3 FY2021Period end 2021-09-30 | $298.01K | -39.74% | -19.62% |
| Q2 FY2021Period end 2021-06-30 | $494.53K | +74.77% | N/A |
| Q1 FY2021Period end 2021-03-31 | $282.96K | -67.84% | N/A |
| Q4 FY2020Period end 2020-12-31 | $879.87K | +137.33% | N/A |
| Q3 FY2020Period end 2020-09-30 | $370.74K | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.